Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia

Uri Rozovski, Maro Ohanian, Farhad Ravandi, Guillermo Garcia-Manero, Stefan Faderl, Sherry Pierce, Jorge Cortes, Zeev Estrov

Research output: Contribution to journalArticle

Abstract

It is thought that the low incidence of central nervous system (CNS) involvement in acute myeloid leukemia (AML) does not justify routine CNS prophylaxis, as high-dose cytarabine eliminates CNS disease. To investigate whether chemotherapy that does not include high-dose cytarabine increases the risk of CNS involvement, the medical records of 1412 newly diagnosed patients with AML were reviewed. In 1370 patients, lumbar puncture (LP) was performed only if clinically indicated, and CNS disease was detected in 45 (3.3%) patients. Another 42 patients underwent routine LP as part of an investigational protocol, and in eight (19%) CNS disease was detected (p < 0.0001). Risk factors included high lactate dehydrogenase, African-American ethnicity and young age. Patients receiving high-dose cytarabine and those who did not had similar rates of CNS involvement. Disease-free survival (DFS) and overall survival were shorter in patients with CNS involvement. It remains to be determined whether routine CNS prophylaxis would improve DFS.

Original languageEnglish (US)
Pages (from-to)1392-1397
Number of pages6
JournalLeukemia and Lymphoma
Volume56
Issue number5
DOIs
StatePublished - May 1 2015
Externally publishedYes

Fingerprint

Acute Myeloid Leukemia
Central Nervous System
Central Nervous System Diseases
Cytarabine
Incidence
Spinal Puncture
Disease-Free Survival
L-Lactate Dehydrogenase
African Americans
Medical Records
Drug Therapy
Survival

Keywords

  • Acute myeloid leukemia
  • Central nervous system
  • Cytarabine
  • Lumbar puncture
  • Risk factors

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Rozovski, U., Ohanian, M., Ravandi, F., Garcia-Manero, G., Faderl, S., Pierce, S., ... Estrov, Z. (2015). Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia. Leukemia and Lymphoma, 56(5), 1392-1397. https://doi.org/10.3109/10428194.2014.953148

Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia. / Rozovski, Uri; Ohanian, Maro; Ravandi, Farhad; Garcia-Manero, Guillermo; Faderl, Stefan; Pierce, Sherry; Cortes, Jorge; Estrov, Zeev.

In: Leukemia and Lymphoma, Vol. 56, No. 5, 01.05.2015, p. 1392-1397.

Research output: Contribution to journalArticle

Rozovski, U, Ohanian, M, Ravandi, F, Garcia-Manero, G, Faderl, S, Pierce, S, Cortes, J & Estrov, Z 2015, 'Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia', Leukemia and Lymphoma, vol. 56, no. 5, pp. 1392-1397. https://doi.org/10.3109/10428194.2014.953148
Rozovski, Uri ; Ohanian, Maro ; Ravandi, Farhad ; Garcia-Manero, Guillermo ; Faderl, Stefan ; Pierce, Sherry ; Cortes, Jorge ; Estrov, Zeev. / Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia. In: Leukemia and Lymphoma. 2015 ; Vol. 56, No. 5. pp. 1392-1397.
@article{e00c117c54a94ae1a4e8aebb6f51ec35,
title = "Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia",
abstract = "It is thought that the low incidence of central nervous system (CNS) involvement in acute myeloid leukemia (AML) does not justify routine CNS prophylaxis, as high-dose cytarabine eliminates CNS disease. To investigate whether chemotherapy that does not include high-dose cytarabine increases the risk of CNS involvement, the medical records of 1412 newly diagnosed patients with AML were reviewed. In 1370 patients, lumbar puncture (LP) was performed only if clinically indicated, and CNS disease was detected in 45 (3.3{\%}) patients. Another 42 patients underwent routine LP as part of an investigational protocol, and in eight (19{\%}) CNS disease was detected (p < 0.0001). Risk factors included high lactate dehydrogenase, African-American ethnicity and young age. Patients receiving high-dose cytarabine and those who did not had similar rates of CNS involvement. Disease-free survival (DFS) and overall survival were shorter in patients with CNS involvement. It remains to be determined whether routine CNS prophylaxis would improve DFS.",
keywords = "Acute myeloid leukemia, Central nervous system, Cytarabine, Lumbar puncture, Risk factors",
author = "Uri Rozovski and Maro Ohanian and Farhad Ravandi and Guillermo Garcia-Manero and Stefan Faderl and Sherry Pierce and Jorge Cortes and Zeev Estrov",
year = "2015",
month = "5",
day = "1",
doi = "10.3109/10428194.2014.953148",
language = "English (US)",
volume = "56",
pages = "1392--1397",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia

AU - Rozovski, Uri

AU - Ohanian, Maro

AU - Ravandi, Farhad

AU - Garcia-Manero, Guillermo

AU - Faderl, Stefan

AU - Pierce, Sherry

AU - Cortes, Jorge

AU - Estrov, Zeev

PY - 2015/5/1

Y1 - 2015/5/1

N2 - It is thought that the low incidence of central nervous system (CNS) involvement in acute myeloid leukemia (AML) does not justify routine CNS prophylaxis, as high-dose cytarabine eliminates CNS disease. To investigate whether chemotherapy that does not include high-dose cytarabine increases the risk of CNS involvement, the medical records of 1412 newly diagnosed patients with AML were reviewed. In 1370 patients, lumbar puncture (LP) was performed only if clinically indicated, and CNS disease was detected in 45 (3.3%) patients. Another 42 patients underwent routine LP as part of an investigational protocol, and in eight (19%) CNS disease was detected (p < 0.0001). Risk factors included high lactate dehydrogenase, African-American ethnicity and young age. Patients receiving high-dose cytarabine and those who did not had similar rates of CNS involvement. Disease-free survival (DFS) and overall survival were shorter in patients with CNS involvement. It remains to be determined whether routine CNS prophylaxis would improve DFS.

AB - It is thought that the low incidence of central nervous system (CNS) involvement in acute myeloid leukemia (AML) does not justify routine CNS prophylaxis, as high-dose cytarabine eliminates CNS disease. To investigate whether chemotherapy that does not include high-dose cytarabine increases the risk of CNS involvement, the medical records of 1412 newly diagnosed patients with AML were reviewed. In 1370 patients, lumbar puncture (LP) was performed only if clinically indicated, and CNS disease was detected in 45 (3.3%) patients. Another 42 patients underwent routine LP as part of an investigational protocol, and in eight (19%) CNS disease was detected (p < 0.0001). Risk factors included high lactate dehydrogenase, African-American ethnicity and young age. Patients receiving high-dose cytarabine and those who did not had similar rates of CNS involvement. Disease-free survival (DFS) and overall survival were shorter in patients with CNS involvement. It remains to be determined whether routine CNS prophylaxis would improve DFS.

KW - Acute myeloid leukemia

KW - Central nervous system

KW - Cytarabine

KW - Lumbar puncture

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=84932107275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84932107275&partnerID=8YFLogxK

U2 - 10.3109/10428194.2014.953148

DO - 10.3109/10428194.2014.953148

M3 - Article

C2 - 25110819

AN - SCOPUS:84932107275

VL - 56

SP - 1392

EP - 1397

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 5

ER -